TickerFacts.

Telomir Pharmaceuticals, Inc. (TELO): EPS (Basic)

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2023-12-31, 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$0.33
Year ended 2025-12-31
$0.482022-12-31: -$0.032023-12-31: $0.482024-12-31: -$0.562025-12-31: -$0.33-$0.33
2022-12-31 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31-$0.33n/m2026-03-17, From 2025-01-01
2024-12-31-$0.56n/c2026-03-17, From 2024-01-01
2023-12-31$0.48n/c2025-02-04, From 2023-01-01
2022-12-31-$0.03n/a2024-03-29, From 2022-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Telomir Pharmaceuticals, Inc. (TELO)2025-12-31-$0.33n/m
Ensysce Biosciences, Inc. (ENSC)2025-12-31-$3.98n/m
Matinas BioPharma Holdings, Inc. (MTNB)2025-12-31-$2.00n/m
Oncolytics Biotech Inc (ONCY)2025-12-31-$0.30n/m
Rocket One Inc. (RKTO)2025-12-31-$0.90n/m
Silo Pharma, Inc. (SILO)2025-12-31-$0.50n/m
Acurx Pharmaceuticals, Inc. (ACXP)2025-12-31-$5.32n/m
CV Sciences, Inc. (CVSI)2025-12-31-$0.01n/m
Serina Therapeutics, Inc. (SER)2025-12-31-$1.91n/m

Compare TELO, ENSC, MTNB, ONCY side by side · Screen every company in Pharmaceutical Preparations ↗